CORD-19:775b90287b44353bee979abb0970a4666022f86d / 612293-612515 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Our cases are unique in that the patients have the same level of phagocyte function but very different phenotypes and highlight the potential difficulty in using level of super oxide production to assess patients for HSCT.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T17195","span":{"begin":0,"end":222},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T17195","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T226","span":{"begin":0,"end":222},"obj":"Sentence"}],"attributes":[{"subj":"T226","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#9693ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#a9ec93"}]}]}}